Shorts

1:15
CMSC 2026: Enhancing MS Clinical Trial Impact
3 months ago
by
Mark Freedman, MD, MSc, HBSc, CSPQ, FANA, FAAN, FRCPC(+1 more)

0:40
AAIC 2026: Rethinking Patient-Centered Neurology Care Today
3 months ago
by
Mirnova Ceide, MD, MS(+1 more)

0:40
Expanding the Approach to AD Care Beyond Pharmacological Treatments
3 months ago
by
Elizabeth Rhodus, PhD, MS(+1 more)

0:58
RECAP: Neurology News Network - July 12th
3 months ago
by
Louie Pasculli

0:40
AAIC 2026: Characterizing Midlife Brain Health in Retired Soccer Players
3 months ago
by
Caleigh G. Lynch, MSc(+1 more)

1:00
The 2024 MS Diagnostic Criteria: More Than a Definition Update
3 months ago
by
Daniel Ontaneda, MD, PhD(+1 more)

0:35
Building a Path Toward Neuropathy Reversal
3 months ago
by
Brian Callaghan, MD, MS

1:02
Diagnosis Is Not the Same as Treatment in Multiple Sclerosis
3 months ago
by
Daniel Ontaneda, MD, PhD(+1 more)

1:46
How Biomarkers Can Help Clarify the MS Diagnostic Gray Zone
3 months ago
by
Daniel Ontaneda, MD, PhD(+1 more)

1:17
RECAP: Neurology News Network - July 4th
3 months ago
by
Louie Pasculli

0:56
Debunking Nerve Pain Myths
3 months ago
by
Mitzi Joi Williams, MD

2:00
Incorporating Biomarkers as Clinical End Points in Nerve Disorder Trials
4 months ago
by
Brett Morrison, MD, PhD

2:07
MicroRNAs Emerge as Promising Biomarkers for Diabetic Neuropathy
4 months ago
by
Brett Morrison, MD, PhD

1:39
RECAP: Neurology News Network - June 27th
4 months ago
by
Louie Pasculli

2:06
SLEEP 2026: Media Training Workshop on Sleep Science
4 months ago
by
Julie Flygare, JD(+1 more)

1:03
ATMRD 2026: Understanding Demoralization in Parkinson Disease
4 months ago
by
Indu Subramanian, MD(+1 more)

2:06
PNS 2026: Debate Between iPSC and Animal Models for Neuropathy Research
4 months ago
by
Ahmet Hoke, MD, PhD

1:13
AHS 2026: Real-World INFUSE Trial of Eptinezumab in Migraine
4 months ago
by
Amaal J. Starling, MD(+1 more)

1:06
SLEEP 2026: Phase 2 Study of Alixorexton in Narcolepsy Type 2
4 months ago
by
Richard Bogan, MD, FCCP, FAASM(+1 more)

0:50
Adapting Exercise for Neurologic Conditions
4 months ago
by
Mitzi Joi Williams, MD

0:58
RECAP: Neurology News Network - June 20th
4 months ago
by
Louie Pasculli

0:35
Steps Needed to Make Diabetic Peripheral Neuropathy Reversible
4 months ago
by
Brian Callaghan, MD, MS

0:57
SLEEP 2026: Key Takeaways From New Hospital-Based Sleep Apnea Guidelines
4 months ago
by
Sunil Sharma, MD(+1 more)

1:04
SLEEP 2026: What Is a Common Sleep-Related Question?
4 months ago
by
Beth Malow, MD, MS(+1 more)

1:11
ATMRD 2026: Overlooked Symptoms of Autonomic Dysfunction in PD
4 months ago
by
Louie Pasculli(+2 more)

1:09
SLEEP 2026: AASM Guideline for Treating Chronic Insomnia
4 months ago
by
Salma Patel, MD(+1 more)

0:35
Biggest Misconceptions Regarding Immune-Mediated Small Fiber Neuropathy
4 months ago
by
Matthew Evans, BM, BCh, DPhil

0:25
Goals for Expanding Knowledge on Programmed Axon Death
4 months ago
by
Michael Coleman, PhD

0:20
Improving Basic Science Objectives for Peripheral Nerve Disorders
4 months ago
by
Carla Taveggia, PhD

0:20
Confocal Corneal Microscopy as an Emerging Biomarker for Peripheral Nerve Disorders
4 months ago
by
Brett Morrison, MD, PhD
Advertisement
Advertisement
Trending on NeurologyLive - Clinical Neurology News and Neurology Expert Insights
1
ELEVIDYS Shows Functional Benefits in Patients With DMD, Dompé Launches Phase 2 Trial of Intranasal Nerve Growth Factor in CP, NeurologyLive Roundtable: The Road Ahead for Precision Medicine in MS
2
FDA Approves Autoinjector for Self-Administered Zilucoplan in Generalized Myasthenia Gravis
3
Satralizumab Reduces MOGAD Relapse Risk in Phase 3 METEOROID Trial
4
RGX-202 Meets Primary End Point in Phase 3 Duchenne Trial
5
